FOLH1 and posterior cortical atrophy: performed PSMA radio-guided surgery in 364 patients with OR PCa yielding a median PFS of 7.8 months but a median therapy-free survival of 35.5 months, which dropped to 19.7 months in patients with ≥ 2 metastases.